Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Yamazaki, E. Koo, D. Selkoe (1996)
Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization.Journal of cell science, 109 ( Pt 5)
P. Eikelenboom, S. Zhan, W. Gool, D. Allsop (1994)
Inflammatory mechanisms in Alzheimer's disease.Trends in pharmacological sciences, 15 12
S. Itagaki, H. Akiyama, Hiroki Saito, P. Mcgeer (1994)
Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's diseaseBrain Research, 645
Haruyasu Yamaguchi, Yoichi Nakazato, Shunsaku Hirai, Mikio Shoji, Y. Harigaya (1989)
Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain.The American journal of pathology, 135 4
M. Goedert, R. Crowther, M. Spillantini (1998)
Tau Mutations Cause Frontotemporal DementiasNeuron, 21
(1997)
many etiologies, one pathogenesis? Proc
PhD Mann, MD Iwatsubo, PhD Cairns, MD Lantos, Mds Nochlin, MDS§ Sumi, MDll Bird, PhD Poorkaj, PhD Hardy, PhD Hutton, PhD Prihar, '. BSc, MD Rossor, M. Haltia, Mann Dma., N. Cairns, P. Lantos, Sumi D, Hardy P, Mann (1996)
Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)Annals of Neurology, 40
M. Podlisny, M. Citron, P. Amarante, R. Sherrington, W. Xia, Jimin Zhang, T. Diehl, G. Lévesque, P. Fraser, C. Haass, E. Koo, P. Seubert, P. George-Hyslop, D. Teplow, D. Selkoe (1997)
Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain TissueNeurobiology of Disease, 3
J. Rogers, S. Webster, L. Lue, L. Brachova, W. Civin, M. Emmerling, B. Shivers, D. Walker, P. Mcgeer (1996)
Inflammation and Alzheimer's disease pathogenesisNeurobiology of Aging, 17
G. Rebeck, Joell Reiter, D. Strickland, B. Hyman (1993)
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactionsNeuron, 11
D. Selkoe (1994)
Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.Annual review of cell biology, 10
Ralf Baumeister, U. Leimer, I. Zweckbronner, C. Jakubek, J. Grünberg, C. Haass (1997)
Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing.Genes and function, 1 2
C. Haass, C. Lemere, A. Capell, M. Citron, P. Seubert, D. Schenk, L. Lannfelt, D. Selkoe (1995)
The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathwayNature Medicine, 1
C. Haass, M. Schlossmacher, A. Hung, C. Vigo‐Pelfrey, A. Mellon, B. Ostaszewski, I. Lieberburg, E. Koo, D. Schenk, D. Teplow, D. Selkoe (1992)
Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 359
W. Xia, Jimin Zhang, R. Perez, E. Koo, E. Koo, D. Selkoe (1997)
Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 94 15
Jie Kang, H. Lemaire, A. Unterbeck, J. Salbaum, Colin Masters, K. Grzeschik, G. Multhaup, K. Beyreuther, B. Müller-Hill (1987)
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 325
M. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, R. Rydel (1992)
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, 12
C. Sturchler-Pierrat,, D. Abramowski, M. Duke, K. Wiederhold, C. Mistl, Sabin Rothacher, B. Ledermann, K. Bürki, P. Frey, P. Paganetti, C. Waridel, M. Calhoun, M. Jucker, A. Probst, M. Staufenbiel, B. Sommer (1997)
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.Proceedings of the National Academy of Sciences of the United States of America, 94 24
A. Roher, J. Lowenson, S. Clarke, A. Woods, R. Cotter, Eric Gowing, M. Ball (1993)
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 22
D. Dickson (1997)
The Pathogenesis of Senile PlaquesJournal of Neuropathology and Experimental Neurology, 56
M. Wolfe, M. Wolfe, W. Xia, B. Ostaszewski, T. Diehl, W. Kimberly, D. Selkoe (1999)
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activityNature, 398
G. Thinakaran, C. Harris, T. Ratovitski, F. Davenport, H. Slunt, D. Price, D. Borchelt, S. Sisodia (1997)
Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors*The Journal of Biological Chemistry, 272
Jimin Zhang, D. Kang, W. Xia, M. Okochi, H. Mori, D. Selkoe, E. Koo (1998)
Subcellular Distribution and Turnover of Presenilins in Transfected Cells*The Journal of Biological Chemistry, 273
A. Capell, J. Grünberg, B. Pesold, A. Diehlmann, M. Citron, R. Nixon, K. Beyreuther, D. Selkoe, C. Haass (1998)
The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex*The Journal of Biological Chemistry, 273
E. Koo, S. Squazzo (1994)
Evidence that production and release of amyloid beta-protein involves the endocytic pathway.The Journal of biological chemistry, 269 26
R. Perez, Hui Zheng, L. Ploeg, E. Koo (1997)
The β-Amyloid Precursor Protein of Alzheimer’s Disease Enhances Neuron Viability and Modulates Neuronal PolarityThe Journal of Neuroscience, 17
X. Li, I. Greenwald (1998)
Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins.Proceedings of the National Academy of Sciences of the United States of America, 95 12
Wilma Wasco, Keith Bupp, M. Magendantz, J. Gusella, Rudolph Tanzi, Frank Solomon (1992)
Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.Proceedings of the National Academy of Sciences of the United States of America, 89 22
R. Black, C. Rauch, C. Kozlosky, J. Peschon, J. Slack, M. Wolfson, B. Castner, K. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K. Schooley, M. Gerhart, Raymond Davis, J. Fitzner, Richard Johnson, R. Paxton, C. March, Douglas Cerretti (1997)
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 385
Jianhua Zhou, U. Liyanage, M. Medina, Carole Ho, A. Simmons, M. Lovett, K. Kosik (1997)
Presenilin 1 interaction in the brain with a novel member of the Armadillo familyNeuroReport, 8
M. Lambert, A. Barlow, B. Chromy, C. Edwards, R. Freed, M. Liosatos, Todd Morgan, I. Rozovsky, B. Trommer, K. Viola, P. Wals, Zhang Chi, C. Finch, G. Krafft, W. Klein (1998)
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.Proceedings of the National Academy of Sciences of the United States of America, 95 11
R. Rosenberg (1997)
The Molecular and Genetic Basis of Neurological Disease
Hui Zheng, Minghao Jiang, M. Trumbauer, D. Sirinathsinghji, R. Hopkins, David Smith, R. Heavens, G. Dawson, S. Boyce, M. Conner, K. Stevens, H. Slunt, S. Sisodia, Howard Chen, L. Ploeg (1995)
β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityCell, 81
J. Busciglio, D. Gabuzda, P. Matsudaira, B. Yankner (1993)
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.Proceedings of the National Academy of Sciences of the United States of America, 90
C. Lemere, F. Lopera, K. Kosik, C. Lendon, J. Ossa, T. Saido, H. Yamaguchi, A. Ruiz, Alonso Martínez, L. Madrigal, L. Hincapié, J. L., D. Anthony, E. Koo, A. Goate, D. Selkoe, J. V. (1996)
The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathologyNature Medicine, 2
M. Harris, K. Hensley, D. Butterfield, R. Leedle, J. Carney (1995)
Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neuronsExperimental Neurology, 131
A. Saunders, W. Strittmatter, D. Schmechel, P. George-Hyslop, M. Pericak-Vance, S. Joo, B. Rosi, J. Gusella, D. Crapper-MacLachlan, M. Alberts (1993)
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.Neurology, 43 8
J. Rogers, Neil Coopers, S. Webster, J. Schultz, P. Mcgeer, S. Styren, W. Civin, L. Brachova, B. Bradt, Pamela, Wardi, I. Lieberburg
Complement activation by f8-amyloid in Alzheimer disease
M. Spillantini, J. Murrell, M. Goedert, M. Farlow, Aaron Klug, B. Ghetti (1998)
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.Proceedings of the National Academy of Sciences of the United States of America, 95 13
David Miller, I. Papayannopoulos, J. Styles, S. Bobin, Y. Lin, K. Biemann, Khadija Iqbal (1993)
Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.Archives of biochemistry and biophysics, 301 1
M. Hutton, C. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R. Petersen, M. Stevens, E. Graaff, E. Wauters, J. Baren, M. Hillebrand, M. Joosse, J. Kwon, P. Nowotny, Li Che, J. Norton, J. Morris, L. Reed, J. Trojanowski, H. Basun, L. Lannfelt, M. Neystat, S. Fahn, F. Dark, T. Tannenberg, P. Dodd, N. Hayward, J. Kwok, P. Schofield, A. Andreadis, J. Snowden, D. Craufurd, D. Neary, F. Owen, B. Oostra, J. Hardy, A. Goate, J. Swieten, D. Mann, T. Lynch, P. Heutink (1998)
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature, 393
J. Harper, Stanislaus Wong, C. Lieber, P. Lansbury (1997)
Observation of metastable Aβ amyloid protofibrils by atomic force microscopyChemistry & Biology, 4
M. Brockhaus, J. Grünberg, S. Röhrig, H. Loetscher, N. Wittenburg, Ralf Baumeister, H. Jacobsen, C. Haass (1998)
Caspase‐mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signalingNeuroReport, 9
R. Sherrington, E. Rogaev, Yan Liang, E. Rogaeva, G. Lévesque, M. Ikeda, H. Chi, Chih-Ping Lin, Gang Li, K. Holman, T. Tsuda, L. Mar, J. Foncin, A. Bruni, M. Montesi, S. Sorbi, I. Rainero, L. Pinessi, L. Nee, I. Chumakov, D. Pollen, A. Brookes, P. Sanseau, R. Polinsky, W. Wasco, H. Silva, J. Haines, M. Pericak-Vance, R. Tanzi, A. Roses, P. Fraser, J. Rommens, P. George-Hyslop (1995)
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseNature, 375
B. Strooper, P. Saftig, K. Craessaerts, H. Vanderstichele, G. Guhde, W. Annaert, K. Figura, F. Leuven (1998)
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor proteinNature, 391
K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, Fusheng Yang, G. Cole (1996)
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 274
Jianyi Ma, A. Yee, H. Brewer, Saumya Das, H. Potter (1994)
Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 372
L. Holcomb, M. Gordon, E. McGowan, Xin Yu, S. Benkovic, P. Jantzen, K. Wright, Irene Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, Kassandra O'Campo, J. Hardy, C. Prada, C. Eckman, S. Younkin, K. Hsiao, K. Duff (1998)
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenesNature Medicine, 4
M. Sano, C. Ernesto, R. Thomas, M. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C. Cotman, E. Pfeiffer, L. Schneider, L. Thal (1997)
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.The New England journal of medicine, 336 17
J. Buxbaum, K. Liu, Y. Luo, J. Slack, K. Stocking, J. Peschon, R. Johnson, B. Castner, D. Cerretti, R. Black (1998)
Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.The Journal of biological chemistry, 273 43
D. Scheuner, C. Eckman, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. Bird, J. Hardy, M. Hutton, W. Kukull, Eric Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, S. Younkin (1996)
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 2
C. Behl, John Davis, R. Lesley, D. Schubert (1994)
Hydrogen peroxide mediates amyloid β protein toxicityCell, 77
E. Rogaev, R. Sherrington, E. Rogaeva, G. Lévesque, M. Ikeda, Yan Liang, H. Chi, Chih-Ping Lin, K. Holman, T. Tsuda, L. Mar, S. Sorbi, B. Nacmias, S. Piacentini, L. Amaducci, I. Chumakov, D. Cohen, L. Lannfelt, P. Fraser, J. Rommens, P. George-Hyslop (1995)
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 geneNature, 376
J. Rogers, N. Cooper, S. Webster, J. Schultz, P. Mcgeer, S. Styren, W. Civin, L. Brachova, B. Bradt, P. Ward (1992)
Complement activation by beta-amyloid in Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 89 21
D. Schmechel, A. Saunders, W. Strittmatter, B. Crain, C. Hulette, S. Joo, M. Pericak-Vance, D. Goldgaber, A. Roses (1993)
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 20
A. Chyung, B. Greenberg, D. Cook, R. Doms, V. Lee (1997)
Novel β-Secretase Cleavage of β-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N CellsThe Journal of Cell Biology, 138
H. Steiner, A. Capell, B. Pesold, M. Citron, P. Kloetzel, D. Selkoe, H. Romig, K. Mendla, C. Haass (1998)
Expression of Alzheimer’s Disease-associated Presenilin-1 Is Controlled by Proteolytic Degradation and Complex Formation*The Journal of Biological Chemistry, 273
D. Blacker, M. Wilcox, N. Laird, L. Rodes, S. Horvath, R. Go, R. Perry, Bracie Watson, S. Bassett, M. McInnis, M. Albert, B. Hyman, R. Tanzi (1998)
Alpha-2 macroglobulin is genetically associated with Alzheimer diseaseNature Genetics, 19
D. Selkoe (1997)
Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 275
J. Jarrett, E. Berger, P. Lansbury (1993)
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.Biochemistry, 32 18
D. Games, David Adams, Ree Alessandrini, R. Barbour, Patricia Borthelette, C. Blackwell, Tony Carr, J. Clemens, T. Donaldson, F. Gillespie, T. Guido, S. Hagopian, K. Johnson-wood, K. Khan, Mike Lee, P. Leibowitz, I. Lieberburg, S. Little, E. Masliah, L. McConlogue, M. Montoya-Zavala, L. Mucke, L. Paganini, E. Penniman, M. Power, D. Schenk, P. Seubert, B. Snyder, F. Soriano, H. Tan, J. Vitale, S. Wadsworth, B. Wolozin, Jun Zhao (1995)
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 373
D. Mann, T. Iwatsubo, H. Fukumoto, Y. Ihara, A. Odaka, N. Suzuki (1995)
Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques.Acta neuropathologica, 90 5
P. Seubert, C. Vigo‐Pelfrey, F. Esch, Michael Lee, H. Dovey, D. Davis, S. Sinha, Michael Schiossmacher, J. Whaley, C. Swindlehurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg, D. Schenk (1992)
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 359
D. Cook, M. Forman, Jane Sung, S. Leight, D. Kolson, T. Iwatsubo, V. Lee, R. Doms (1997)
Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cellsNature Medicine, 3
D. Skovronsky, R. Doms, V. Lee (1998)
Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in CultureThe Journal of Cell Biology, 141
S. Sisodia (1992)
Beta-amyloid precursor protein cleavage by a membrane-bound protease.Proceedings of the National Academy of Sciences of the United States of America, 89 13
DMA Mann (1996)
Amyloid beta protein (A-beta) deposition in chromosome 14-linked Alzheimer's disease—predominance of A-beta (42(43))Ann. Neurol., 40
W. Strittmatter, A. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. Salvesen, A. Roses (1993)
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90
P. Mcgeer, E. Mcgeer (1995)
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseasesBrain Research Reviews, 21
Jie Shen, R. Bronson, D. Chen, W. Xia, D. Selkoe, S. Tonegawa (1997)
Skeletal and CNS Defects in Presenilin-1-Deficient MiceCell, 89
C. Wild‐Bode, T. Yamazaki, A. Capell, U. Leimer, H. Steiner, Y. Ihara, C. Haass (1997)
Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*The Journal of Biological Chemistry, 272
P. Poorkaj, T. Bird, E. Wijsman, E. Nemens, R. Garruto, L. Anderson, A. Andreadis, W. Wiederholt, M. Raskind, G. Schellenberg (1998)
Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 43
John Hardy (1997)
The Alzheimer family of diseases: many etiologies, one pathogenesis?Proceedings of the National Academy of Sciences of the United States of America, 94 6
T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, Y. Ihara (1994)
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 13
C. Lemere, C. Lemere, J. Blusztajn, H. Yamaguchi, T. Wisniewski, T. Saido, D. Selkoe (1996)
Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque FormationNeurobiology of Disease, 3
E. Levy-Lahad, W. Wasco, P. Poorkaj, D. Romano, J. Oshima, W. Pettingell, Chang-En Yu, P. Jondro, Stephen Schmidt, Kai Wang, A. Crowley, Ying-Hui Fu, S. Guénette, D. Galas, E. Nemens, E. Wijsman, T. Bird, G. Schellenberg, R. Tanzi (1995)
Candidate gene for the chromosome 1 familial Alzheimer's disease locusScience, 269
Gang Yu, Fusheng Chen, G. Lévesque, M. Nishimura, Dong-Mei Zhang, L. Lévesque, E. Rogaeva, Donghong Xu, Yan Liang, Monika Duthie, P. George-Hyslop, P. Fraser (1998)
The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin*The Journal of Biological Chemistry, 273
H. Slunt, G. Thinakaran, C. Koch, A. Lo, R. Tanzi, S. Sisodia (1994)
Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).The Journal of biological chemistry, 269 4
M Hutton (1998)
Association of missense and 5′-splice-site mutations in tau with the inherited FTDP-17Nature, 393
E. Schroeter, Jeffrey Kisslinger, Raphael Kopan (1998)
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domainNature, 393
S. Lee, U. Liyanage, P. Bickel, W. Xia, P. Lansbury, K. Kosik (1998)
A detergent-insoluble membrane compartment contains A beta in vivo.Nature medicine, 4 6
A. Chyung, B. Greenberg, D. Cook, R. Doms, V. Lee (1997)
Novel b-Secretase Cleavage of b-Amyloid Precursor Protein in the Endoplasmic Reticulum / Intermediate Compartment of NT 2 N Cells
K. Bales, T. Verina, R. Dodel, Yansheng Du, L. Altstiel, M. Bender, P. Hyslop, E. Johnstone, S. Little, D. Cummins, P. Piccardo, B. Ghetti, S. Paul (1997)
Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 17
W Xia (1998)
Presenilin 1 regulates the processing APP C-terminal fragments and the generation of amyloid β-protein in ER and GolgiBiochemistry, 37
P. Seubert, T. Oltersdorf, Michael Lee, R. Barbour, C. Blomquist, D. Davis, K. Bryant, L. Fritz, D. Galasko, L. Thal, I. Lieberburg, D. Schenk (1993)
Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptideNature, 361
(1995)
evidence that an initially deposited species is Ab42(43)
A. Weidemann, K. Paliga, U. Dürrwang, C. Czech, G. Evin, Colin Masters, K. Beyreuther (1997)
Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor proteinNature Medicine, 3
P. Wong, Hui Zheng, Hua Chen, M. Becher, D. Sirinathsinghji, M. Trumbauer, Howard Chen, D. Price, L. Ploeg, S. Sisodia (1997)
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesodermNature, 387
G. Thinakaran, D. Borchelt, Michael Lee, H. Slunt, L. Spitzer, Grace Kim, T. Ratovitsky, F. Davenport, C. Nordstedt, M. Seeger, J. Hardy, A. Levey, S. Gandy, N. Jenkins, N. Copeland, D. Price, S. Sisodia (1996)
Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In VivoNeuron, 17
B. Wolozin, K. Iwasaki, P. Vito, J. Ganjei, E. Lacaná, T. Sunderland, Boyu Zhao, J. Kusiak, W. Wasco, L. D’Adamio (1996)
Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer MutationScience, 274
D. Levitan, I. Greenwald (1995)
Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease geneNature, 377
A. Lorenzo, B. Yankner (1994)
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences of the United States of America, 91 25
A. Biere, B. Ostaszewski, Hongwei Zhao, S. Gillespie, S. Younkin, D. Selkoe (1995)
Co-expression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: analysis of βAPP processingNeurobiology of Disease, 2
G. Glenner, Caine Wong (1984)
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.Biochemical and biophysical research communications, 122 3
D. Walsh, A. Lomakin, G. Benedek, M. Condron, D. Teplow (1997)
Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.The Journal of biological chemistry, 272 35
T. Yamazaki, D. Selkoe, E. Koo (1995)
Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neuronsThe Journal of Cell Biology, 129
(1995)
analysis of bAPP processing
M. Shoji, T. Golde, J. Ghiso, T. Cheung, S. Estus, L. Shaffer, X. Cai, McKay Dm, R. Tintner, B. Frangione (1992)
Production of the Alzheimer amyloid beta protein by normal proteolytic processing.Science, 258 5079
L. Hendriks, C. Duijn, P. Cras, M. Cruts, W. Hul, F. Harskamp, A. Warren, M. McInnis, S. Antonarakis, Jean-Jacques Martin, A. Hofman, C. Broeckhoven (1992)
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein geneNature Genetics, 1
Seung-Jae Lee, U. Liyanage, P. Bickel, W. Xia, P. Lansbury, K. Kosik (1998)
A detergent-insoluble membrance compartment contains Aβ in vivoNature Medicine, 4
S. Qian, P. Jiang, X. Guan, Gurparkash Singh, M. Trumbauer, Hong Yu, Howard Chen, L. Ploeg, Hui Zheng (1998)
Mutant Human Presenilin 1 Protects presenilin 1 Null Mouse against Embryonic Lethality and Elevates Aβ1–42/43 ExpressionNeuron, 20
T. Hartmann, S. Bieger, Babara Brühl, P. Tienari, N. Ida, D. Allsop, G. Roberts, C. Masters, C. Dotti, K. Unsicker, K. Beyreuther (1997)
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptidesNature Medicine, 3
E. Levy, M. Carman, I. Fernandez‐Madrid, M. Power, I. Lieberburg, S. Duinen, G. Bots, W. Luyendijk, B. Frangione (1990)
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.Science, 248 4959
D. Levitan, T. Doyle, Denise Brousseau, Michael Lee, G. Thinakaran, H. Slunt, S. Sisodia, I. Greenwald (1996)
Assessment of normal and mutant human presenilin function in Caenorhabditis elegans.Proceedings of the National Academy of Sciences of the United States of America, 93 25
J. Buxbaum, Kang-Nian Liu, Yuxia Luo, J. Slack, K. Stocking, J. Peschon, Richard Johnson, B. Castner, D. Cerretti, R. Black (1998)
Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor*The Journal of Biological Chemistry, 273
T. Tomita, S. Tokuhiro, T. Hashimoto, Keiko Aiba, T. Saido, K. Maruyama, T. Iwatsubo (1998)
Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42.The Journal of biological chemistry, 273 33
W. Xia, J. Zhang, B. Ostaszewski, W. Kimberly, P. Seubert, E. Koo, J. Shen, D. Selkoe (1998)
Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.Biochemistry, 37 47
J. Trojanowski (1993)
The Molecular and Genetic Basis of Neurological DiseaseJournal of Neuropathology and Experimental Neurology, 52
C. Pike, D. Burdick, A. Walencewicz, C. Glabe, C. Cotman (1993)
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, 13
K. Evans, E. Berger, C. Cho, K. Weisgraber, P. Lansbury (1995)
Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 92 3
G. Thinakaran, J. Regard, C. Bouton, C. Harris, D. Price, D. Borchelt, S. Sisodia (1998)
Stable Association of Presenilin Derivatives and Absence of Presenilin Interactions with APPNeurobiology of Disease, 4
Studies of the molecular basis of Alzheimer's disease exemplify the increasingly blurred distinction between basic and applied biomedical research.The four genes so far implicated in familial Alzheimer's disease have each been shown to elevate brain levels of the self-aggregating amyloid-β protein, leading gradually to profound neuronal and glial alteration, synaptic loss and dementia. Progress in understanding this cascade has helped to identify specific therapeutic targets and provides a model for elucidating other neurodegenerative disorders.
Nature – Springer Journals
Published: Jun 24, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.